{"transactions":[{"id":729930,"issuer":{"id":7254,"kind":"organization","name":"Nasus Pharma Ltd","symbol":"NSRX"},"owners":[{"id":27957,"kind":"person","name":"Teleman Dan Benjamin","position":1,"cik":"0002122500","reported_name":"Teleman Dan Benjamin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-22T11:12:42.000Z","date":"2026-06-17","kind":"purchase","planned":false,"acquired":true,"shares":6550,"price":3.1,"value":20305.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of: (i) 30,696 ordinary shares, no par value per share (\"Ordinary Shares\"), and (ii) 132,845 Ordinary Shares issuable upon exercise of outstanding share options that are exercisable within 60 days."}],"balance_after":163541,"source":{"system":"sec-edgar","filing":"0001493152-26-029484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029039/000149315226029484/ownership.xml","form_type":"4"}},{"id":802337,"issuer":{"id":7254,"kind":"organization","name":"Nasus Pharma Ltd","symbol":"NSRX"},"owners":[{"id":27957,"kind":"person","name":"Teleman Dan Benjamin","position":1,"cik":"0002122500","reported_name":"Teleman Dan Benjamin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-23T01:44:10.000Z","date":"2026-04-22","kind":"purchase","planned":false,"acquired":true,"shares":2900,"price":3.76,"value":10904.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of: (i) 24,146 ordinary shares, no par value per share (\"Ordinary Shares\"), and (ii) 132,845 Ordinary Shares issuable upon exercise of outstanding share options that are exercisable within 60 days."}],"balance_after":156991,"source":{"system":"sec-edgar","filing":"0001493152-26-018607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029039/000149315226018607/ownership.xml","form_type":"4"}},{"id":822348,"issuer":{"id":7254,"kind":"organization","name":"Nasus Pharma Ltd","symbol":"NSRX"},"owners":[{"id":27957,"kind":"person","name":"Teleman Dan Benjamin","position":1,"cik":"0002122500","reported_name":"Teleman Dan Benjamin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-01T11:31:31.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.04,"value":30600.0,"ownership":{"direct":true},"balance_after":21246,"source":{"system":"sec-edgar","filing":"0001493152-26-014503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029039/000149315226014503/ownership.xml","form_type":"4"}}]}